Home
Biosensors for Medical Wearables
October 24 - October 25, 2022
Biosensors for Medical Wearables

SAE Media Group and Medical Design Briefs Present
Biosensors for Medical Wearables
October 24-25, 2022 | Boston, MA, USA
-------------------------------------------------------------------------------------------

The global wearable biosensors market is a rapidly expanding industry with increasingly growing potential for applications in healthcare and technological advances. With potential in remote patient monitoring, diagnosis and detection of disease, biosensors and wearable devices are gaining substantial interest due to their opportunities to offer continuous and reliable physiological information allowing for better support of patient needs.

As part of SAE Media Group’s leading series of medical device conferences, this year’s event will bring together big pharma, device developer and component manufacturers to explore the key drivers and innovations of the wearable medical biosensors landscape.
 

 ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Day 1 will uncover the latest technologies advancing the therapeutic scope of biosensors and bringing medical grade wearables to the home featuring insights from BioIntellisense and MedRhythms, the potential of wearable sensors for decentralized diagnostic testing and a future outlook of the industry with case studies and discussions from Pfizer, Digital Medicine Society (DiMe) and the American Telemedicine Association (ATA).
 

Day 2 will take an in depth look at challenges and unmet needs of the industry including, battery technologies, regulatory compliance, flexible sensors and adhesives for advanced user-centric clinical grade measurement. With growing digital application, the 2022 agenda will also assess the potential of Artificial Intelligence coupled with sensors to managing digital outcomes and data with addresses from Beacon Biosignals and Biofourmis. Real-world examples will bring light to the importance of ensuring technical developments of wearable biosensors are bringing optimal solutions for patients in a healthcare setting.

 

Don’t miss this opportunity to network with the leading big pharma, device developer and component manufacturers as the advancing industry of wearable biosensors moves forward.

FEATURED SPEAKERS

Amanda Donovan

Amanda Donovan

Director, Emerging Priorities & Innovation, Takeda
Carolyn Walsh

Carolyn Walsh

Chief Commercial Officer, BioIntelliSense, Inc.
Carrie Northcott

Carrie Northcott

Senior Director and Project Lead, Digital Medicine and Translational Imaging (DMTI), Early Clinical Development (ECD), Pfizer Inc
Christine Guo

Christine Guo

Chief Scientific Officer, ActiGraph
Eric Richardson

Eric Richardson

Vice President of Applied Research, MedRhythms, Inc.
Greg Schulte

Greg Schulte

VP of Hardware, Cala Health
Jacob Donoghue

Jacob Donoghue

CEO and Co-Founder, Beacon Biosignals
James Mault, MD

James Mault, MD

Founder and CEO, BioIntelliSense, Inc.
Jennifer Goldsack

Jennifer Goldsack

CEO, Digital Medicine Society (DiMe)
Johannes Kreuzer

Johannes Kreuzer

CEO, Cosinuss
John Ralston

John Ralston

CEO and Founder, Neursantys, Inc.
Jordan Brayanov

Jordan Brayanov

Head, Digital Strategy, Digital Health Sciences, Takeda
Kate Gunning

Kate Gunning

Managing Partner, Focus Academy
Katie Chowdhury

Katie Chowdhury

Director, Regulatory Affairs, Digital & Medical Device Team, Emerging Technology & Combination Products, AbbVie
Krupal Patel

Krupal Patel

Assistant Member, Head & Neck - Endocrine Oncology, Moffitt Cancer Center
Mark D Price

Mark D Price

Assistant Professor, Attending Surgeon, Orthopedic Surgery, Massachusetts General Hospital, Harvard Medical School
Pierre-Alexandre Fournier

Pierre-Alexandre Fournier

Co-Founder/CEO, Hexoskin
Richard Bolander

Richard Bolander

Senior Wearable Design Engineer, TracPatch Health
Samir Shah

Samir Shah

Director, AstraZeneca
Sara Silacci

Sara Silacci

Chief Strategy Officer and Senior Managing Director, Massachusetts General Hospital
Sherrie Trigg

Sherrie Trigg

Director of Medical Content and Editor-in-Chief, Medical Design Briefs
Shruti Iyer

Shruti Iyer

Principal Innovation Architect, Clinical Innovation, Oracle Health Sciences
Tero-Pekka Alastalo

Tero-Pekka Alastalo

Chief Medical Officer and General Manager, US Operations, CardioSignal Inc
Xina Quan

Xina Quan

Co-Founder and CEO, PyrAmes, Inc

Amanda Donovan

Director, Emerging Priorities & Innovation, Takeda
Amanda Donovan

Amanda Donovan is in Takeda’s Innovation & Data department within the R&D Global Development organization. She is part of the Emerging Priorities & Innovation team, who are focused on creating the next generation clinical trial, where technology and the patient journey converge. With over 15 years of industry experience and a strong background in Global Clinical Operations and Partnership Engagement, Amanda believes in collaboration and partnership to drive success, change, and return on investment. She holds a Bachelor of Science degree in Business Management with a dual focus on Biotechnology and Global Business Management from Babson College.

Andreas Caduff

Strategic Advisory Board, Digital Medicine Society (DiMe)
Andreas Caduff

Andreas Caduff has been a driving force in the development of non-invasive and contextualized physiological monitoring. He was serving as CTO of Solianis where he orchestrated the development of non-invasive glucose monitoring. He then founded Biovotion and served for 7 years as CEO, offering a state-of-the-art user-centric, analytics driven ecosystem, powered by medical wearable technology. Biovotion received several international awards and high calibre endorsements for its innovations, including an award from the XPrize Foundation. Biovotion was acquired by Biofourmis in 2019. Today he is working at the interface of secured medical technology, physiological monitoring and data science, towards a more holistic view of health.

Carolyn Walsh

Chief Commercial Officer, BioIntelliSense, Inc.
Carolyn Walsh

In this role, Carolyn is responsible for the marketing and commercial performance of the BioIntelliSense business. BioIntelliSense is a Denver-based continuous health monitoring and clinical intelligence company. BioIntelliSense’s Data-as-a-Service (DaaS) platfrom seamlessly captures multi-parameter vital signs, physiologic biometrics and symptomatic events through an effortless user experience. The medical-grade BioButton® wearable device, combined with advanced analytics, makes early detection simple from in-hospital to home.

Prior to joining BioIntelliSense, Carolyn Walsh served as the Vice President and Head of Sales and Business Development for the Fitbit Health Solutions group providing leading wearable devices, along with enterprise grade software and services, to inspire and deliver continuous health improvement.
Prior to joining Fitbit Health Solutions, Walsh served as Senior Director of Global Marketing for Qualcomm Life, Inc. Ms. Walsh joined the Qualcomm Life leadership team from HealthyCircles, an enterprise healthcare software-as-a-service platform company, where she led Business Development and Client Services. HealthyCircles was acquired by Qualcomm Life in April 2013.
Prior to HealthyCircles, Walsh served as the Global Director of New Ventures, Franchise Development for Johnson & Johnson Diabetes Care. Walsh was responsible for the digital health strategy, software innovations and formulating growth strategies for emerging markets of India and China. While at Johnson & Johnson, Walsh served in global commercial leadership roles spanning acute, health care professional and consumer engagement channels.
Before transitioning into the health care industry, Walsh was a versatile executive with Coca-Cola with a proven track record of success in sales management, strategic marketing, brand building and channel development in a major U.S. market along with international assignments in Poland and New Zealand.
Walsh holds a Bachelor's of Science degree from Northern Illinois University and MBA from Loyola University of Chicago.
 

Carrie Northcott

Senior Director and Project Lead, Digital Medicine and Translational Imaging (DMTI), Early Clinical Development (ECD), Pfizer Inc
Carrie Northcott

Carrie Northcott, PhD is a Director/ Project Lead within Digital Medicine and Translational Imaging (DMTI), Early Clinical Development (ECD) at Pfizer. She leads a driven and diverse team that is evaluating and validating the use of wearable digital devices to more fully understand and characterize physiological endpoints, such as quantitatively measuring night-time scratch and sleep. Carrie has a diverse scientific background in Pharmacology, Toxicology, and Physiology which provides unique insight into understanding how these novel digital endpoints provide meaningful information to patients, doctors and researchers to better treat and understand diseases.

Christine Guo

Chief Scientific Officer, ActiGraph
Christine Guo

Christine Guo leads the clinical and data science team at ActiGraph, responsible for the scientific strategy and services supporting ActiGraph's leadership in digital health technology. Christine brings 15+ years’ experience in clinical research and a vision for leveraging technology in clinical trials and practice. Prior to ActiGraph, Christine was Head of Scientific Innovation at Biogen Healthcare Solutions, leading the clinical development and validation of Biogen's digital health products (Software as Medical device) in multiple sclerosis, neuromuscular and neurodegenerative diseases. Christine brings unique scientific insights by bridging across clinical and technical disciplines and is passionate about leveraging data and technology to improve people's health. Christine holds a B.A. in biological sciences from Peking University and Ph.D. in neuroscience from Stanford university.

Eric Richardson

Vice President of Applied Research, MedRhythms, Inc.
Eric Richardson

Eric Richardson has worked in R&D leadership roles for over thirty-five years, during which time he honed his talents for engineering, product development and strategic marketing for international public companies. Eric’s executive responsibilities included driving R&D team innovation and developing high value partner relationships. Eric is currently the VP of Applied Research at MedRhythms and contributes his extensive knowledge of audio engineering, biomechanics and the neuroscience of music cognition. He is passionate about music and its ability to improve people’s lives in a meaningful way. Previously, Eric was president of Fwave, Inc., a software product development company that created enTrainer, a mobile app for music-based fitness and sports performance and cybersecurity simulation systems for global financial institutions. Eric holds degrees from Dartmouth College and Berklee College of Music.

Greg Schulte

VP of Hardware, Cala Health
Greg Schulte

Greg currently leads hardware and firmware development at Cala Health. He has 20+ years of experience in product strategy, design, and engineering for companies and clients of all sizes focused in medical, utility, and consumer electronics. Greg co-founded Guide Medical Ventures in 2011, managing strategic vision and technology for a portfolio of 6 start-ups in the medical device space. More recently. Greg began working with Cala while leading engineering at Mindtribe, a boutique hardware development consultancy, designing connected products for Google, Samsung, Lyft, Facebook, and dozens of startups (acquired by Accenture). Greg started his career at Medtronic as a mechanical design engineer in neurological devices and honed his engineering leadership at Intelect Medical (acquired by Boston Scientific), Enpath Medical and EnteroMedics.

Jacob Donoghue

CEO and Co-Founder, Beacon Biosignals
Jacob Donoghue

Jake translates scientific innovation into clinical interventions. He recently completed his MD from Harvard Medical School and PhD in neuroscience from MIT, leading research into the effects of neuroactive compounds on brain network activity. His published works span epilepsy, cognition and machine learning methods for quantifying pharmacological effects on neural activity.

James Mault, MD

Founder and CEO, BioIntelliSense, Inc.
James Mault, MD

James Mault, MD, FACS, is the Founder and Chief Executive Officer of BioIntelliSense, a Data-as-a-Service (DaaS) platform company, delivering breakthrough medical-grade biosensor technology with unique clinical intelligence for scalable remote patient monitoring.

Prior to BioIntelliSense, Dr. Mault served as Senior Vice President and Chief Medical Officer of Qualcomm Life for over five years, where his leadership responsibilities included Strategic Planning and Business Development, Mergers and Acquisitions, New Product Innovation, Clinical Program and Regulatory Oversight, Health Policy and Government Affairs, Global Spokesperson and Public Relations. Dr. Mault came to Qualcomm Life through its 2013 acquisition of HealthyCircles, a Care Coordination and Remote Patient Monitoring Platform Company founded and led by Dr. Mault in 2009. Prior to starting HealthyCircles, he was the Medical Director of the Health Solutions Group at Microsoft.

Dr. Mault has more than 35 years of experience in senior executive positions in the Health IT and Medical Device industry as well as clinical medicine. He has founded five Health IT and medical device companies, raising over $150 million in working capital and leading these companies to develop novel devices and software technologies, FDA approvals, strategic partnerships with numerous Fortune 500 companies, culminating in M&A or IPO exit transactions. He is the named inventor of over 80 issued and pending patents for a variety of novel health IT and medical device innovations. He has been board-certified in both General Surgery and Cardiothoracic Surgery, having specialized in heart and lung transplantation, thoracic oncology and critical care. He has conducted academic medical research under grant awards from the National Institutes of Health, American Cancer Society, and others. He is the author of more than 60 scientific articles, chapters and books in the published medical literature.

Dr. Mault received his B.S. in Biology and Medical Degree from the University of Michigan and conducted his General Surgery and Cardiothoracic Surgery residency training at Duke University Medical Center. Dr. Mault provides global thought-leadership on the future of technology and healthcare delivery, serving on numerous Boards and leadership positions including the Board of Directors of Bose Corporation, Executve Board of the Consumer Technology Association’s (CTA), Chairman of the American Telemedicine Association Clinical Trials Board and the Board of Trustees for the Astronaut Scholarship Foundation.
 

Jasmin Imsirovic

Associate Director, Data Sciences Institute, Takeda
Jasmin Imsirovic

Jasmin Imsirovic is an Associate Director in Digital Health Sciences at Takeda where he advises clinical teams on the strategy and implementation of digital devices in clinical trials. His focus is on leading validation studies of devices, assessing new technologies and supporting teams in device selection and digital biomarker development. Prior to joining Takeda, Jasmin was a Principal Scientist at Respiratory Motion Inc where he oversaw algorithm and software development for an FDA-cleared respiratory monitor, as well as its implementation in clinical studies. He attended Boston University where he earned BS, MS and PhD degrees in Biomedical Engineering.

Jennifer Goldsack

CEO, Digital Medicine Society (DiMe)
Jennifer Goldsack

Jennifer C. Goldsack co-founded and serves as the CEO of the Digital Medicine Society (DiMe), a 501(c)(3) non-profit organization dedicated to advancing digital medicine to optimize human health. Jennifer’s research focuses on applied approaches to the safe, effective, and equitable use of digital technologies to improve health, healthcare, and health research. She is a member of the Roundtable on Genomics and Precision Health at the National Academies of Science, Engineering and Medicine and serves on the World Economic Forum Global Leadership Council on mental health.

Previously, Jennifer spent several years at the Clinical Trials Transformation Initiative (CTTI), a public-private partnership co-founded by Duke University and the FDA. There, she led development and implementation of several projects within CTTI’s Digital Program and was the operational co-lead on the first randomized clinical trial using FDA’s Sentinel System.

Jennifer spent five years working in research at the Hospital of the University of Pennsylvania, first in Outcomes Research in the Department of Surgery and later in the Department of Medicine. More recently, she helped launch the Value Institute, a pragmatic research and innovation center embedded in a large academic medical center in Delaware.

Jennifer earned her master’s degree in chemistry from the University of Oxford, England, her masters in the history and sociology of medicine from the University of Pennsylvania, and her MBA from the George Washington University. Additionally, she is a certified Lean Six Sigma Green Belt and a Certified Professional in Healthcare Quality. Jennifer is a retired athlete, formerly a Pan American Games Champion, Olympian, and World Championship silver medalist.
 

Johannes Kreuzer

CEO, Cosinuss
Johannes Kreuzer

Dr. Johannes Kreuzer studied electronic engineering at the Technical University of Munich from 2000-2005. Topic of his PhD was vital signs monitoring in daily life. During university time and later, he worked for companies like Epcos, EADS, Airbus, Daimler and Pilatus. Together with his wife Greta he founded the company cosinuss° end of 2011. cosinuss° is a technology company based in Munich and specialized on in-ear vital signs monitoring for sports, medicine and workers safety.

John Ralston

CEO and Founder, Neursantys, Inc.
John Ralston

Dr. Ralston is a pioneer in the integration of clinical grade wearable devices and advanced data analytics to improve patient access to unobtrusive continuous and remote healthcare management. At Neursantys he is focused on improving the diagnosis and treatment of complex neurophysiological conditions caused by aging, injuries, and disease, in collaboration with healthcare delivery and research teams working to improve patient care and reduce healthcare delivery costs. John earned B.Sc. degrees in Physics and Electrical Engineering from M.I.T., a PhD in Electrical Engineering from Cornell University, and the MSc degree in Management of Technology from the MIT Sloan School of Management.

Jordan Brayanov

Head, Digital Strategy, Digital Health Sciences, Takeda
Jordan Brayanov

Jordan Brayanov, PhD is the Head of Digital Strategy within the Data Sciences Institute at Takeda. In this role, he oversees the strategic development and deployment of Digital Health Solutions and oversees the design and implementation of Decentralized Clinical Trials within clinical programs across Takeda R&D. Prior to joining Takeda, Jordan served as Vice President of Research at Respiratory Motion -- a leader in respiratory volume monitoring. His experience and research focus are on the design, development, and deployment of patient-centric tools and measurement equipment, advanced data modeling, and data visualization. Jordan holds a PhD in Computational Neuroscience from Harvard.

Kate Gunning

Managing Partner, Focus Academy
Kate Gunning

Kate Gunning is focused on strategic market development and technology commercialization for the Life Sciences, Healthcare and Clean technology sectors. Kate’s expertise is evaluating and developing market opportunities in the US for emerging Life science and Healthtech companies and their inventive technologies.
Kate’s career includes a broad range of Life science and Med tech expertise, from Nuclear Medicine to Clinical Chemistry, Genomics, and Automation, she has worked with both academic and industry leaders.
With an expansive network both in the US and internationally, she is frequently tapped for advice and guidance on the development of the Biotech and Cleantech industries in the US and overseas. Kate serves as a mentor with Silicon Valley based accelerators, including UC Berkeley’s Center for Entrepreneurship and Technology.

Katie Chowdhury

Director, Regulatory Affairs, Digital & Medical Device Team, Emerging Technology & Combination Products, AbbVie
Katie Chowdhury

Katie joined AbbVie in May 2021 as a Director of Regulatory Affairs for the newly formed Digital & Medical Device Team in the Emerging Technology & Combination Product group. In this role, Katie and her team support internally developed SaMD projects providing regulatory strategy during development and GRL support prior to global launch. In addition, Katie is the lead Device Regulatory for the ABBV-RGX-314 partnership between AbbVie and Regen X Bio supporting both key ancillary devices required for the Subretinal and Suprachoroidal delivery of the biologic.
Prior to joining AbbVie, Katie held a biomedical engineer and lead reviewer position at the US FDA Center for Devices and Radiological Health (CDRH) in the Cardiovascular Device Division (DCD) in the Office of Device Evaluation (ODE) from 2006 until 2015. In this role she was the lead reviewer for interventional cardiovascular devices including guidewires, guide catheters, bare metal, drug eluting and bioabsorbable stents. After completing the Leadership Readiness program in 2015, Katie joined the Office of Orphan Products Development (OOPD) in the Commissioner’s Office where she led review of the Humanitarian Use Device (HUD) designations, supported the Pediatric Device Consortium and Orphan Clinical Trials grants. Her last official role at the Agency took her back to CDRH where she headed the partnership with the Medical Device Innovation Consortium (MDIC) in the External Partnerships sector and supported regulatory science project development across multiple initiatives including Digital Health, In Vitro Diagnostics, Early Feasibility Studies (EFS), Case for Quality and Science of Patient Input.
Katie holds her undergraduate degree from the University of Pittsburgh (cum laude) in Biomedical Engineering (2004) and her master’s degree from Maquette University and the Medical College of Wisconsin in Healthcare Technology Management (2005). Katie resides in NW Washington DC with her husband, Atiq, and twin boys, Isaac and Isaiah.
 

Krupal Patel

Assistant Member, Head & Neck - Endocrine Oncology, Moffitt Cancer Center
Krupal Patel

Dr. Krupal Patel is an Assistant Member in the Department of Head and Neck–Endocrine Oncology at H. Lee Moffitt Cancer Center, Tampa, Florida.

He is fellowship trained the Head and Neck Microvascular Reconstructive surgeon, and board-certified in Otolaryngology by the Royal College of Physicians and Surgeons in Canada and by the American Board of Otolaryngology - Head and Neck Surgery.

His practice includes focus on the minimally invasive surgeries including transoral robotic surgery for oropharynx cancers and expanded endonasal approaches for sinonasal/skull base cancers, as well as resection of head and neck cancers and microvascular reconstructive surgeries.

He has ongoing projects and publications in improving outcomes in head and neck cancer patients, cancer care delivery including financial toxicity, virtual health and real time patient monitoring to design just-in-time interventions to improve patient outcomes.

Mark D Price

Assistant Professor, Attending Surgeon, Orthopedic Surgery, Massachusetts General Hospital, Harvard Medical School
Mark D Price

Mark D. Price, MD, PhD provides patients with the highest level and quality of care, using all of the latest techniques and available research, in an effort to restore their function and alleviate their pain.
Dr. Price specializes in sports medicine shoulder surgery. Before coming to Mass General, Dr. Price was at the UMass Medical School and UMass Memorial Medical Center in Worcester where he helped establish one of New England's busiest comprehensive shoulder programs. He performs arthroscopic surgery of the shoulder, as well as total shoulder replacement and complex shoulder reconstructions.
Dr. Price earned his MD from Harvard Medical School and PhD in Medical Physics from MIT. He completed the Harvard Combined Orthopaedic Residency Program where he was the Administrative Chief Resident at Mass General, and he won both resident and faculty teaching awards. He completed a fellowship in sports medicine and shoulder reconstructive surgery at Mass General. At the conclusion of his training he was awarded the Herodicus Society traveling fellowship and studied with Dr. Jim Andrews at the American Sports Medicine Institute in Birmingham, AL, and Dr. David Altchek at the Hospital for Special Surgery in NY.
Dr. Price is Head Team Physician and Medical Director for the New England Patriots and a Team Physician for the Boston Red Sox. He is on the faculty of Harvard Medical School where he is an Assistant Professor and teaches in the anatomy and pathology courses. He is a Captain in the US Navy Reserves and has served in combat operations in Afghanistan, where he was awarded the Bronze Star Medal. He is board certified in orthopedic surgery with a subspecialty certification in Orthopedic Sports Medicine. He is a fellow of the American Academy of Orthopedic Surgery (FAAOS), Arthroscopy Association of North (FAANA) America, American Orthopedic Association (FAOA), and the American College of Surgeons (FACS). He is an active member of the American Orthopaedic Society for Sports Medicine, Society of Military Orthopedic Surgeons, American Shoulder and Elbow Surgeons, and New England Shoulder and Elbow Society.
 

Orel Swenson

Medical Director for Digital Therapeutics, Biofourmis
Orel Swenson

Orel Swenson, MD, MBA, is the Medical Director for Digital Therapeutics at Biofourmis. Prior to Biofourmis, Dr. Swenson worked at Riverflow Growth Fund, a Virginia based venture capital fund. His preceding experience includes practice as an emergency medicine physician, including serving as an associate medical director and director of observation medicine. Additionally, Dr. Swenson has extensive entrepreneurial experience, including cofounding a freestanding emergency department, and he holds an MBA from Duke University.

Pierre-Alexandre Fournier

Co-Founder/CEO, Hexoskin
Pierre-Alexandre Fournier

Pierre-Alexandre Fournier is an engineer, scientist, designer and entrepreneur, co-founder and CEO of Hexoskin, a Montreal-based company focused on clinical-grade wearable sensors and AI software for health and clinical research.
Hexoskin launched in 2013 the first iPhone compatible smart clothing for health monitoring, which won several international awards. In 2018 Hexoskin launched a remote health monitoring system for astronauts doing research aboard the International Space Station. Hexoskin products designed by Pierre-Alexandre and his team are now used by hundreds of research organisations around the world to collect medical data and push the boundaries of medical knowledge in real-life settings. Pierre-Alexandre is also an advocate for transparency in healthcare, patient empowerment, and healthcare innovation through design.

Prashant Kumar

CEO, TechBlocks Inc
Prashant Kumar

Prashant is the Founder & CEO of TechBlocks, a global software engineering firm with a strong Digital Health practice.
Prashant has over 20 years of experience working with business leaders to design, develop and execute challenging technology projects across multiple industries, including biosensor and health wearables, Web 3.0 and Blockchain, IOT and real-time connected platforms from Fortune 50 to well-funded successful startups.
Prashant has a Bachelors in Engineering, Certificate in Internet Management and leads a global team of over 2,700 engineers & product pioneers.

Richard Bolander

Senior Wearable Design Engineer, TracPatch Health
Richard Bolander

Richard Bolander, PhD, earned his degree in Biomedical Engineering in 2012 with a concentration in impact biomechanics. He currently serves as the head of product development at TracPatch Health, focusing on new product design, algorithm development, intellectual property, clinical studies and other applied research activities. Prior to joining Tracpatch, Dr. Bolander was a concussion researcher and product developer, primarily focusing on algorithms, data science and testing and verification of novel technologies. His most notable work was the development of the Riddell InSite and InSite analytics platforms, which are used to measure head impacts of football players.

Samir Shah

Director, AstraZeneca
Samir Shah

At AstraZeneca, Dr. Shah develops regulatory strategies to achieve worldwide approval of drug/device combination products, medical devices, and software across all therapeutic areas. He previously worked at Teva Pharmaceuticals where he led regulatory activities leading to approvals of the first integrated smart/digital inhalers, PROAIR DIGIHALER, AIRDUO DIGIHALER, and ARMONAIR DIGIHALER. Previously, he was a formulation scientist at Merck / Schering-Plough for respiratory and nasal products. Dr. Shah earned his B.S. from Case Western Reserve University in Polymer Science Engineering and a PhD in Biomedical Engineering Wake Forest University School of Medicine.

Sara Silacci

Chief Strategy Officer and Senior Managing Director, Massachusetts General Hospital
Sara Silacci

Sara Silacci
Chief Strategy Officer, Massachusetts General Hospital
Senior Managing Director, Center for Innovation in Digital HealthCare
Affiliate Faculty, Mass General Brigham Clinical Informatics
Massachusetts General Hospital, founding member of Mass General Brigham (formerly Partners HealthCare)

Sara is the Chief Strategy Officer and Senior Managing Director for Digital Health, Research, and Connected Systems at Massachusetts General Hospital. In these roles, she manages all aspects of the initiatives and programs relative to data and technology investments, research, innovation, commercialization and strategic operations. Sara is a founding executive of MGH’s Center for Innovation in Digital HealthCare, established in 2018 to guide and support the lifecycle of Mass General’s Digital Health portfolio. This includes articulating internal and external market needs, solution design, identifying growth opportunities, creating business strategies, and securing strategic partnerships to achieve the vision.

Prior to this role Sara served as a Senior Managing Director of Development for multiple departments across Mass General. During her eight-year tenure, annual philanthropic and sponsored research support increased ten-fold. Prior to Mass General, Sara served as a Director of Development for Boston Children’s Hospital where in partnership with the Board of Trustees and Hospital leadership, Sara spearheaded the initiative to establish a hospital presence in strategic national and international markets. Sara began her career at Memorial Sloan Kettering Cancer Center working in research operations, public affairs and corporate relations.

Sara is a member of the National Comprehensive Cancer Network Foundation Board of Trustees, and an Executive Member for the Board for Fern Health and CarePassport. She was named as one of the Boston Business Journal’s Top 40 Under 40 in a year that will never be published so as to preserve her youth.

Sara earned a BA in Communications and Science from Fordham University in New York, NY.
 

Sherrie Trigg

Director of Medical Content and Editor-in-Chief, Medical Design Briefs
Sherrie Trigg

Sherrie Trigg is editor and director of medical content for Medical Design Briefs magazine. MDB is dedicated to providing the engineering community with information on the latest medical technology and biomedical breakthroughs and advances they can apply to the development of new medical devices, instruments, and systems. Ms. Trigg has been a part of the medical device industry for more than 20 years, having served previously as director of medical content for Medical Design and as editor-in-chief and director of medical content for MD&DI magazines. She has an extensive background in technical editing in areas including, pharmaceuticals, biotechnology, analytical chemistry, electromagnetic compatibility, and plastics manufacturing. She has a BA in journalism from the University of Oregon.

Shruti Iyer

Principal Innovation Architect, Clinical Innovation, Oracle Health Sciences
Shruti Iyer

Shruti Iyer is a Principal Innovation Architect supporting Clinical Innovation in the Health Sciences Global Business Unit at Oracle. Prior to Oracle, Shruti worked at Medtronic, where she was a subject matter expert in end-to-end medical device product development focusing on remote monitoring solutions for late stage heart failure patients.

Shruti has a Bachelors Degree in Biomedical Engineering and an M.S. in Medical Device Innovation from the University of Minnesota-Twin Cities, where she was a Technological Leadership Institute Fellow. She is energized about driving complex and critical decisions in a highly regulated environment and is a thought leader with passion to empower patients to be in control of their health.

Tero-Pekka Alastalo

Chief Medical Officer and General Manager, US Operations, CardioSignal Inc
Tero-Pekka Alastalo

Tero-Pekka Alastalo, MD, PhD is the Chief Medical Officer and President of CardioSignal Inc. He is a health care entrepreneur, investor, advisor, and board member. He has 10+ years of clinical and translational research experience and is an Adjunct Professor of Pediatrics at the University of Helsinki. He specialized in Pediatric Cardiology and did his postdoctoral training at Stanford University. He was a co-founder of Blueprint Genetics, a genetic testing laboratory for human rare diseases, that was acquired by Quest Diagnostics in 2020. At Blueprint Genetics he had several executive roles from commercial to medical affairs. He left Blueprint Genetics to join CardioSignal in 2021. He is an expert in cardiovascular medicine, genomic medicine, and medical devices for cardiovascular diseases.

Xina Quan

Co-Founder and CEO, PyrAmes, Inc
Xina Quan

Co-founder & CEO, PyrAmes Inc., has led interdisciplinary teams that have transformed advanced materials research into innovative commercial products for photonics, telecommunications, optoelectronics, and consumer electronics applications for over four decades. She has been developing PyrAmes’ technology with Stanford Prof. Zhenan Bao since 2015. Prior to founding PyrAmes, Xina led R&D programs at Artificial Muscle Inc. (acquired by Bayer MaterialScience and Parker Hannifin), Cambrios, Lumileds Lighting, DigiLens, and AT&T Bell Labs. She has SB and SM degrees from MIT and a PhD from Princeton, all in Chemical Engineering. Xina is a registered patent agent with the US Patent Office and has more than 30 issued or pending US patents.

sponsors

Conference agenda

clock

8:00

Registration & Coffee

clock

9:00

Chairman's Opening Remarks

James Mault, MD, Founder and CEO, BioIntelliSense, Inc.

clock

9:10

Medical Grade Wearables and Continuous Remote Monitoring from In-Hospital to Home

James Mault, MD, Founder and CEO, BioIntelliSense, Inc.

  • A new generation of medical grade wearable sensors can enable continuous multi-parameter patient monitoring both in-hospital and at-home.
  • With the effortless simplicity of passive continuous monitoring, the asynchronous data streams generated by these wearable devices, combined with scalable exception management algorithms, enable more proactive, efficient and scalable models of care.
  • These new remote care technology solutions can reduce length of stay, detect negative trends early in their course, and deliver better care to more patients at a fraction of the cost.
  • clock

    9:50

    Designing wearables for real-time clinical thinking algorithms

    Eric Richardson, Vice President of Applied Research, MedRhythms, Inc.

  • In digital therapeutic devices, there are a class of products whose clinical responses are delivered synchronously to the patient based on real-time inputs from biosensors. These devices differ from wearables that track biomarkers and activities on daily hourly or daily basis.
  • Real-time wearables don’t have the luxury of post-processing entire data sets. Hardware and algorithm design must accommodate the constraints of data processing with low-latency and high reliability requirements,
  • Using machine learning and other techniques early in the data acquisition pipeline.
  • Wireless biosensors are preferred, so edge processing algorithms on the biosensor hardware reduces data transmission and conserves battery life.
  • This presentation will discuss design strategies that balance the competing requirements of real-time medical wearables.
  • clock

    10:30

    Morning Coffee

    clock

    11:00

    Cala Trio: Using Biosensors to personalize treatment of tremors

  • Incorporating sensors to benefi t patient experience
  • Overview of CALA Trio therapy
  • How each of CALA trio’s sensors improve patient therapy
  • Greg Schulte, VP of Hardware, Cala Health

    clock

    11:40

    Fireside Chat: What does the future hold for Medical Wearable Biosensors

    Chief of Medical Design Briefs, Sherrie Trigg, will be engaging with recognised thought leaders of the industry: American Telemedicine Association (ATA) board member; James Mault, MD, and CEO of the Digital Medicine Society (DiMe); Jennifer Goldsack.


    Our esteemed panellists will discuss the growing potentials of this exciting industry, engaging in highlights of their experiences of the evolving landscape of wearable sensors, the latest trends to watch out for, and insights into the future of this rapidly accelerating field of medicine.

    Sherrie Trigg, Director of Medical Content and Editor-in-Chief, Medical Design Briefs

    James Mault, MD, Founder and CEO, BioIntelliSense, Inc.

    Jennifer Goldsack, CEO, Digital Medicine Society (DiMe)

    clock

    12:20

    Monitoring a post-surgical episode of care using wearable technologies

    Richard Bolander, Senior Wearable Design Engineer, TracPatch Health

  • Developing a multi-sensor array to characterize range of motion across a joint
  • Incorporating patient – centric features to increase the probability of success of an intervention
  • Creating a holistic solution to bridge the gap between patients and providers
  • Analysing episode of care data to solve challenges within in the musculoskeletal space
  • clock

    13:00

    Networking Lunch

    clock

    14:00

    Enabling remote cardiac monitoring to detect major heart disease

    Tero-Pekka Alastalo, Chief Medical Officer and General Manager, US Operations, CardioSignal Inc

  • Introducing a new approach to remote heart health monitoring with motion sensor technology: Gyrocardiography, a non-invasive technique for assessing heart motion
  • Technology that can run on smartphones, offering unmatched accessibility in virtual care models
  • A high-quality signal: Accurate performance with a wide range of smartphone models and different body characteristics. Presenting results from our multi-center clinical studies, and published clinical and technical validations
  • Technology that enables detection of major heart disease, such as heart failure, coronary artery disease and aortic stenosis
  • clock

    14:40

    Making the promise of “Patient-Centric Care leveraging Wearable Devices” with Design Thinking And Patient-Centric Experience a reality

    Prashant Kumar, CEO, TechBlocks Inc

  • Bridging & Unifying the best of “Wellness Wearables” and “Wearable Medical Devices” – Challenges, Solutions and Approaches
  • Nuances of COE (engineering, QA and product teams) : Difference between success and failure – Case Study and Reusable frameworks
  • The business case of integrating sensor data with consumer health platforms, including Apple Health Kit, Google Fit, Samsung Health, and Oura to provide the user a 360-degree view of their health
  • Taking the best solutions and practices from other industries to fast track your go to market strategy
  • clock

    15:20

    Afternoon Tea

    clock

    15:50

    Wearable device integration of neurophysiological diagnostic and therapeutic capabilities

    John Ralston, CEO and Founder, Neursantys, Inc.

  • Assessing the utility of non-invasive wearable sensors to classify and quantify impairments to multiple neurophysiological systems
  • Assessing the utility of non-invasive neurostimulation techniques to counteract neurophysiological disruptions caused by aging, injuries, or disease
  • Addressing challenges in the design, prototyping, and manufacturing of devices that integrate the above diagnostic and therapeutic capabilities into an unobtrusive wearable form factor
  • Applications to a growing range of neurological conditions, including concussions, vestibular disorders, Parkinson’s disease, stroke, multiple sclerosis, peripheral neuropathies, and invasive neurosurgeries
  • clock

    16:30

    Panel Discussion: Integrating sensor generated data into data platforms to power clinical research and patient care

  • A cross-industry collaboration to articulate value, define needs, and advance a framework for best practices
  • Challenges in data handling to practically introducing sensors at scale in clinical research and patient care environments
  • What does the industry need with regard to regulations, standards and guidance to accelerate the opportunities of sensor data in medicine?
  • Takeaways from the study: next steps for industry to allow clinicians, patients, and researchers to use sensor generated data to make better decisions, faster
  • Jennifer Goldsack, CEO, Digital Medicine Society (DiMe)

    Shruti Iyer, Principal Innovation Architect, Clinical Innovation, Oracle Health Sciences

    Krupal Patel, Assistant Member, Head & Neck - Endocrine Oncology, Moffitt Cancer Center

    Jasmin Imsirovic, Associate Director, Data Sciences Institute, Takeda

    clock

    17:10

    Chair’s Closing Remarks and Close of Day One

    clock

    17:20

    Virtual On Demand: Assessing accuracy, reliability and usability of in-ear vital signs monitoring

  • An introduction to the current landscape of vital signs monitoring
  • Verifying biosensor features and applicability for continuous monitoring of vital signs
  • Human factors considerations for in-ear wearable device design
  • Components of remote patient monitoring systems for detection, analysis, and transmission of raw data
  • *Virtual presentation will be available on post-conference portal

    Johannes Kreuzer, CEO, Cosinuss

    clock

    8:30

    Registration & Coffee

    clock

    9:00

    Chairman's Opening Remarks

    Andreas Caduff, Strategic Advisory Board, Digital Medicine Society (DiMe)

    clock

    9:10

    Assessing the evolving landscape of wearable devices for monitoring and remote diagnostics

    Andreas Caduff, Strategic Advisory Board, Digital Medicine Society (DiMe)

  • Growing technologies in wearable monitoring in health and medicine
  • Analyzing the use of consumer technology for medical applications: the good and bad
  • Uncovering the biosensor technologies to look out for in the near future
  • The sky’s the limit – how should industry be focusing their R&D for optimal opportunities from sensor technologies?
  • clock

    9:50

    Panel Discussion: Decentralized Trial Design for Today and the Future

  • The growth of connected devices, medical-grade data and remote technologies is setting the stage for a more
  • decentralized future for clinical trials.
  • Learn about clinical trial design that addresses the challenges of access, diversity and equity.
  • What are the emerging technology platforms that are helping to facilitate decentralized trials and what is still needed to support decentralized trials for the future?
  • Carolyn Walsh, Chief Commercial Officer, BioIntelliSense, Inc.

    Jordan Brayanov, Head, Digital Strategy, Digital Health Sciences, Takeda

    Katie Chowdhury, Director, Regulatory Affairs, Digital & Medical Device Team, Emerging Technology & Combination Products, AbbVie

    Carrie Northcott, Senior Director and Project Lead, Digital Medicine and Translational Imaging (DMTI), Early Clinical Development (ECD), Pfizer Inc

    Amanda Donovan, Director, Emerging Priorities & Innovation, Takeda

    Sara Silacci, Chief Strategy Officer and Senior Managing Director, Massachusetts General Hospital

    clock

    10:30

    Morning Coffee

    clock

    11:00

    No two devices are created equal

  • The past, present and future of sensor-based digital health technology (DHT) and novel digital endpoints (NDEs) for use in clinical investigations and beyond.
  • How technology and pharma can work together to continue the advancement of DHTs and novel clinical endpoints in clinical trials
  • Case Study: Wearable device comparisons and sensor performance evaluation
  • Carrie Northcott, Senior Director and Project Lead, Digital Medicine and Translational Imaging (DMTI), Early Clinical Development (ECD), Pfizer Inc

  • The past, present and future of sensor-based digital health technology (DHT) and novel digital endpoints (NDEs) for use in clinical investigations and beyond.
  • How technology and pharma can work together to continue the advancement of DHTs and novel clinical endpoints in clinical trials
  • Case Study: Wearable device comparisons and sensor performance evaluation
  • Christine Guo, Chief Scientific Officer, ActiGraph

    clock

    11:40

    Panel Discussion: Clinical Value and Utility of Advancements in Remote Core Technologies

  • Exploring the fast-growing capabilities of wearables in the clinic as a result of developments in technologies
  • How are monitoring technologies being used to evolve a standard of care within the walls of hospitals and health system facilities?
  • How can data driven continuous care models start to automate care?
  • The ongoing pathway of monitoring patients with complex care needs
  • Carolyn Walsh, Chief Commercial Officer, BioIntelliSense, Inc.

    Mark D Price, Assistant Professor, Attending Surgeon, Orthopedic Surgery, Massachusetts General Hospital, Harvard Medical School

    Sara Silacci, Chief Strategy Officer and Senior Managing Director, Massachusetts General Hospital

    Kate Gunning, Managing Partner, Focus Academy

    clock

    12:20

    Pairing Remote EEG Monitoring with Large-Scale Computing to Go Beyond the Analysis Capabilities of Human Experts

  • Wearable biosensors will provide scalable continuous brain health metrics to accelerate precision medicine for patients with severe neurological disease.
  • The rise of machine learning and improvement in wearable sensor technologies has created a unique moment in time where EEG will become scalable in a way that was never possible with traditional hardware and expert-dependent interpretation.
  • Novel machine learning algorithms and large clinical datasets are poised to transform how brain disorders are treated. Using clinical-grade data from remote EEG monitoring, machine learning accelerates the discovery of neurobiomarkers and the development of new treatments for patients with neurological, psychiatric or sleep
  • disorders.
  • Neurobiomarkers are helping to progress new discoveries from development to targeted deployment into clinical trials and novel therapeutic areas.
  • Jacob Donoghue, CEO and Co-Founder, Beacon Biosignals

    clock

    13:00

    Networking Lunch

    clock

    14:00

    Overcoming challenges in long-term adhesives for wearable sensors

  • Assessing the growing landscape of smart clothing for medical applications
  • Challenges in long-term medical wearables and insights into the design and development of flexible textile sensors to overcome hurdles in adhesives
  • Case Studies of cardiac, pulmonary and respiratory medical application of smart textile sensors
  • Uncovering the future potential and opportunities to further long-term medical sensor technologies
  • Pierre-Alexandre Fournier, Co-Founder/CEO, Hexoskin

    clock

    14:40

    Transforming the delivery of health care through advanced sensor measurement

    Xina Quan, Co-Founder and CEO, PyrAmes, Inc

  • Challenges in accurate blood pressure measurement for newborns to seniors
  • The technology behind PyrAmes’ flexible sensors for non-invasive continuous blood pressure monitoring
  • Supportive evidence for the FDA-designated breakthrough device
  • Next steps and future applications for the flexible sensor
  • clock

    15:20

    Afternoon Tea

    clock

    15:50

    What’s new in wearable biosensors and AI/ML-based remote patient management

    Orel Swenson, Medical Director for Digital Therapeutics, Biofourmis

  • How artificial intelligence (AI)/machine learning (ML) coupled with biosensors can improve drug safety and efficacy
  • How Biofourmis is leveraging wearables and AI to identify objective measures of pain in clinical studies
  • Ten years after the first patient was treated with CAR-T therapy: Sensors and predictive analytics monitor patients post-treatment to prevent life-threatening issues
  • Future clinical and therapeutic potential of AI/ML coupled with biosensors
  • clock

    16:30

    Tales from the Trenches

    Kate Gunning, Managing Partner, Focus Academy

  • Considerations in commercializing health technology
  • Incorporating meaningful data for adoption
  • Data integration and dataflows for healthcare decision making
  • Strategic planning and evidence building discussion
  • clock

    17:10

    Chair’s Closing Remarks and Close of Day Two

    clock

    17:20

    Virtual On Demand: What is Electromagnetic Compatibility and Why do Regulators Want Your Biosensors to Comply?*

    Samir Shah, Director, AstraZeneca

  • Disasters caused by electromagnetic disturbances
  • What is 60601-1-2 and what do all the terms mean?
  • Why regulators still ask for testing on electronics while relaxing requirements on software

    *Virtual presentation will be available on post-conference portal


  • Director, Emerging Priorities & Innovation
    Takeda
    Strategic Advisory Board
    Digital Medicine Society (DiMe)
    Chief Commercial Officer
    BioIntelliSense, Inc.
    Senior Director and Project Lead, Digital Medicine and Translational Imaging (DMTI), Early Clinical Development (ECD)
    Pfizer Inc
    Chief Scientific Officer
    ActiGraph
    Vice President of Applied Research
    MedRhythms, Inc.
    VP of Hardware
    Cala Health
    CEO and Co-Founder
    Beacon Biosignals
    Founder and CEO
    BioIntelliSense, Inc.
    Associate Director, Data Sciences Institute
    Takeda
    CEO
    Digital Medicine Society (DiMe)
    CEO
    Cosinuss
    CEO and Founder
    Neursantys, Inc.
    Head, Digital Strategy, Digital Health Sciences
    Takeda
    Managing Partner
    Focus Academy
    Director, Regulatory Affairs, Digital & Medical Device Team, Emerging Technology & Combination Products
    AbbVie
    Assistant Member, Head & Neck - Endocrine Oncology
    Moffitt Cancer Center
    Assistant Professor, Attending Surgeon, Orthopedic Surgery
    Massachusetts General Hospital, Harvard Medical School
    Medical Director for Digital Therapeutics
    Biofourmis
    Co-Founder/CEO
    Hexoskin
    CEO
    TechBlocks Inc
    Senior Wearable Design Engineer
    TracPatch Health
    Director
    AstraZeneca
    Chief Strategy Officer and Senior Managing Director
    Massachusetts General Hospital
    Director of Medical Content and Editor-in-Chief
    Medical Design Briefs
    Principal Innovation Architect, Clinical Innovation
    Oracle Health Sciences
    Chief Medical Officer and General Manager, US Operations
    CardioSignal Inc
    Co-Founder and CEO
    PyrAmes, Inc

    Sponsors

    Exhibitors

    Official Media Partner

    Key Media Partners

    Supporters

    Biosensors for Medical Wearables Brochure 2022

    Download

    Conference Chair Letter

    Download

    Speaker Biographies

    Download

    Past Attendees

    Download

    Past Presentation - Rhoda Au, Boston University

    Download

    Past Presentation - James Mault, BioIntelliSense

    Download

    Past Presentation - Philip Wilson, Celanese

    Download

    Sponsors


    Movesense

    Sponsors
    http://www.movesense.com

    Movesense helps companies create new wearable sensor solutions for digital and remote healthcare, sports, and everyday life.

    With the programmable, medically registered Movesense ECG and movement sensor, you can quickly create and test product concepts and bring them to the mass market without having to invest in your own hardware development. The platform includes practical developer tools and illustrative sample code, and the sensor’s open programming interface gives you direct access and full control over sensor raw data.

    The accuracy of Movesense Medical sensor has been validated in several scientific studies. One of the studies shows that the 1-lead ECG data of Movesense Medical can be used instead of a reference 12-lead ECG for detecting atrial fibrillation.

    The company's flexible, Finland-based production ensures that you can easily scale the volume according to your business needs and get the sensor with your own logo even from small quantities. With Movesense, you can significantly shorten the time to market and reduce the development costs of your own wearable medical device. Instead of worrying about hardware development and manufacturing, you can focus directly on creating customer value through the actual end-user application.


    Exhibitors


    Raumedic

    Exhibitors
    http://www.raumedic.com

    RAUMEDIC serves Pharma / Biopharma / Cell and Gene Therapy - with first class tubing for fluid transfer and fluid handling applications.

    Benefit from Raumedic's 70+ years of experience as a single source tubing supplier - with an in-house materials department, in-house product development and tried and trusted manufacturing expertise at five different production sites in three countries.

    With Raumedic as your supplier, you can count on:

    Standards compliance and validation

    Biocompatibility

    Low extractable values

    Increased flow rates / Cell Growth yield

    Discover innovative tubing from Raumedic - In stock and ready to ship!

    • Standards compliance and validation

    • Biocompatibility

    • Low extractable values

    • Increased flow rates / Cell Growth yield

    • Platinum cured Silicone Tubing

    • Platinum cured Braided Silicone Tubing (high pressure)

    • Thermoplastic Elastomer Tubing (TPE)

    • Tubing sets - bespoke customer design



    TechBlocks

    Exhibitors
    http://https://www.tblocks.com/

    TechBlocks is a Canadian-based leader in custom software development for digital health companies and product engineering for companies globally. TechBlocks is more than just a development firm – we have been serving customers in health care, life sciences, clinical therapy, pharmaceuticals and other industries like automotive, retail, utilities, telecommunications, financial services, and healthcare for over 15 years with clients that include Toyota, Honda, Bell, S&P Global, Bausch Health, and more.


    Media Partners


    DiMe (Digital Medicine Society)

    Official Media Partner
    https://www.dimesociety.org/

    DiMe is a global non-profit and the professional home for all members of the digital medicine community. Together, we tackle the toughest digital medicine challenges, develop clinical-quality resources on a technology timeline, and deliver these actionable resources to the field via open-source channels and educational programs. Join us to advance the ethical, effective, equitable, and safe use of digital medicine to redefine healthcare and improve lives.

    Media Partners


    Pharma Journalist

    Key Media Partners
    http://www.pharmajournalist.com

    Pharma Journalist is a product of Kellen Media. Pharma Journalist is one of the leading website covering the need of global Pharmaceutical Industry. Articles like latest news, trends, analysis, market report, press releases, whitepapers, case studies, etc. published on pharmajournalist.com helps Industry professionals and decision makers to stay on the top of this fast-paced industry. Pharma Journalist aims of providing fast and informative articles to its readers and subscribers.


    On Drug Delivery

    Key Media Partners
    http://www.ondrugdelivery.com/subscribe

    ONdrugDelivery provides 30,000 readers throughout global pharma/biopharma, with the latest, most pertinent industry information and intelligence about the drug delivery-related ideas, technologies, services and products the sector is developing. Established in 2004, and trusted throughout the industry for its high quality contributions from leading drug delivery experts, ONdrugDelivery is a must for pharma / biotech industry professionals who need to know what’s going on in drug delivery. Subscribe online today to the print or free digital edition: www.ondrugdelivery.com/subscribe.


    American Pharmaceutical Review

    Key Media Partners
    http://www.americanpharmaceuticalreview.com

    Start receiving your free copy today. American Pharmaceutical Review is a review of the drug pipeline from the late discovery phase through manufacturing. American Pharmaceutical Review prides itself on having the most relevant, unbiased and informative editorial in the industry. You will find that all of our editorial is highly technical and written by government agencies, consultants, academics, and large pharmaceuticals companies. American Pharmaceutical Review covers several key topics that are important to drug production:Separations and purification, Drug Delivery, Biopharmaceutical Processing, Biopharmaceutical Development, Formulation development, Manufacturing, Microbiology, Instrumentation, Spectroscopy


    Medical Design Briefs

    Key Media Partners
    http://WWW.TECHBRIEFS.COM/SUBSCRIBE/MDB/SMIEAST21

    Medical Design Briefs (MDB) is the only publication for the medical OEM market dedicated to medical product design engineers and managers. We offer timely, accurate, quality content and editorial, and we report on engineering-related topics that are at the core of the latest medical technologies. From materials to manufacturing, we dive into the technical side of bringing medical devices to market. From biosensors to cybersecurity, we keep our fingers on the pulse of the hottest trends and topics that may augment or disrupt medical technology.

    Media Partners


    MedTech Innovation

    Supporters
    http://www.med-technews.com

    Med-Tech Innovation is the leading multi-platform communication brand for the UK and Irish medical design and manufacturing industries. Our portfolio includes Med-Tech Innovation Expo an annual exhibition and conference; Med-Tech Innovation News a print magazine and online news source; weekly newsletters and an ever-growing social media community. Med-Tech Innovation reaches a unique medical and healthcare audience eager to source solutions to their latest challenges. We connect innovators – whether they be major OEMs or fledgling start-ups –with a community of designers and engineers ready to help bring medical devices to market, quickly and at scale.


    Mass Device

    Supporters
    https://www.massdevice.com/

    MassDevice provides day-to-day coverage of the medtech and medical device industry, with stories about devices that save lives, the people behind them and the trends driving businesses forward. Our reach extends across the industry, with up-to-date news on clinical trials, regulatory processes research and development, financial updates and legal news for spaces including orthopedic devices, surgical robotics, replacement heart valves and plenty more. We’re the most trusted resource in the medical device industry that’s inside the boardroom of every medical device company in the country. Our fully interactive brand focuses on covering the ways in which medtech businesses are offering safer, more effective and cost-efficient treatments around the world. The publication serves the medtech and medical device industry, supplier and contract manufacturers, government organizations/agencies, research hospitals, medical centers, universities and more. Our readers include high-level medtech executives, trade associations, entrepreneurs, corporate and academic researchers, engineers and government officials including regulators. MassDevice is your top resource for all medical device and medtech news, owned by Cleveland-based WTWH Media. We stand by journalistic ethics to provide the most up-to-date, accurate and fairly reported information for our readers.


    Pharmalicensing

    Supporters
    http://www.pharmalicensing.com

    Pharmalicensing (www.pharmalicensing.com) is the premier biopharmaceutical Open Innovation resource designed for professionals involved with partnering, licensing and business development worldwide. Actively supporting all forms of partnering and in- and out-licensing activities, Pharmalicensing utilizes the unique online Showcase Profiling & Discover services, as well as its renowned Partnering Search service leveraging its global network of industry experts, to enable companies to identify and engage with appropriate partners around the world. Pharmalicensing is actively utilized by many tens of thousands of industry professionals each month. Pharmalicensing is a division of Cognis Group, Inc.


    Pharmaceutical Outsourcing

    Supporters
    http://www.pharmoutsourcing.com

    Pharmaceutical Outsourcing, the journal dedicated to pharmaceutical and biopharmaceutical contract services. With regular sections on contract manufacturing, contract research, contract packaging, formulation/development services, contract analytical testing, APIs, stability testing, clinical research and other areas, we bring the most complete coverage of trends and issues in the industry to our 15,000 readers in North America.


    Technology Networks

    Supporters
    http://go.technologynetworks.com/subscribe-to-newsletters

    Founded in 2000, Technology Networks is established as the leading news provider for life science and drug discovery professionals. In addition, we provide unique content including webcasts, videos, application notes and posters from recent conferences. Our portfolio now includes around 30 focussed scientific communities, all of which are accessible free of charge within TechnologyNetworks.com


    Drug Discovery Today

    Supporters
    http://www.drugdiscoverytoday.com/

    Drug Discovery Today covers the whole of the preclinical drug discovery process. The reviews are cutting edge, written by experts in their respective fields and cover all aspects of drug discovery from genomic and proteomic approaches, computational drug design, medicinal chemistry and the translation of these sciences to therapies.


    ASD MEDIA

    Supporters
    http://www.asd-network.com

    Professionals in the Aerospace & Defence market use the ASD Media internet platforms to:
    • Be informed on the latest market developments; www.asd-network.com
    • Find the latest business news; www.asd-network.com
    • Find the upcoming events; www.asd-network.com
    • Find companies and organizations; www.asdsource.com
    • Distribute news globally. www.asdwire.com
    The ASD Media platforms are well known and used intensively, your company is able to benefit from these large numbers of users. Be informed with ASD-Network; Create exposure for your company with ASDSource, distribute your news with ASDWire or advertise with us, build your brand and increase traffic to your company’s website.

    For more detailed information please contact with: ASD MEDIA
    Stefan.koopman@asdmedia.nl


    ATA - American Telemedicine Association

    Supporters
    https://www.americantelemed.org/

    We represent a broad and inclusive member network of leading healthcare delivery systems, academic institutions, technology solution providers and payers, as well as partner organizations and alliances, working to advance industry adoption of telehealth, promote responsible policy, advocate for government and market normalization, and provide education and resources to help integrate virtual care into emerging value-based delivery models.


    Pharmiweb

    Supporters
    http://www.pharmiweb.com

    Established in October 2003, PharmiWeb Solutions is an energetic, innovative provider of web-based solutions for the pharmaceutical sector, with customers such as AstraZeneca, Roche, Servier Laboratories, and Merck With solutions in three key areas: Online Publishing, e-Business and Mobile Computing, we deliver connectivity – between people and applications – unlocking islands of data and knowledge. We own some of the sector’s most innovative Online Publications: PharmiWeb.com, HospitalPharma.com and Detail-Direct.com. We are actively developing solutions for Mobile Computing platforms. For example, our PharmiTabTM e-pharmacy solution runs real-time patient data and prescribing transactions in a busy hospital environment, on a TabletPC, wireless client/server platform. e-Business solutions range from e-Detailing, to Online Market Research, all designed to increase reach, increase sales, and to reduce administration and costs.


    Mednous

    Supporters
    http://www.MedNous.com

    MedNous is a print publication and website about medical innovation in Europe. It carries exclusive interviews with companies that are at the forefront of medical technology, as well as contributor articles from prominent practitioners. Our mission is to identify significant advances in medicine and to explain how this innovation is being commercialised. In doing so, we talk to venture capitalists about what products and platforms they are supporting. We report on how regulators cope with the accelerating pace of innovation. And we regularly cover the latest developments in the discovery and development of new medical concepts in the area of antibodies, vaccines, small molecules, regenerative medicine and nanomedicines. MedNous combines the English word for medicine with the Greek word for intellect. And those with nous are readers of our publication. Visit our website: www.mednous.com


    Pharmacircle

    Supporters
    http://www.pharmacircle.com

    PharmaCircle is an innovative knowledge management company serving the current and future global leaders in the Pharmaceutical and Biotechnology related industries. PharmaCircle is a one stop information and analysis source for pipeline, products, clinical trials, drug delivery technologies, deals and acquisitions, company financials, venture capital investments, product sales, pharmaceutical services, news, patents and more….

    Sheraton Boston Hotel

    39 Dalton Street
    Boston 02199
    USA

    Sheraton Boston Hotel

    Travelers will reap benefits of Sheraton Boston Hotel's prime location in downtown Boston, in the thriving neighborhood of Back Bay. Nestled in the heart of the city, our hotel is directly connected to the Prudential Center and steps away from the many shops and restaurants of Copley Place. We're also within walking distance of Fenway Park, the Charles River, Copley Square and much more.

    Aside from a superior Boston, MA location, we also boast an unbeatable array of amenities for your convenience. Break a sweat in our hotel's state-of-the-art fitness center, enjoy the use of New England's largest indoor-outdoor saltwater pool or indulge in some pampering at Green Tangerine Spa & Salon, our full-service salon and spa. We also boast comprehensive meeting and event facilities, perfect for hosting both corporate functions and weddings in downtown Boston. However you choose to spend your time here, we can assure you that the best of the city will be within reach at Sheraton Boston Hotel.
     

    HOTEL BOOKING FORM

    Title

    SubTitle
    speaker image

    Content


    Title


    Description

    Download

    Title


    Description

    Download

    Title


    Description


    Download


    WHAT IS CPD?

    CPD stands for Continuing Professional Development’. It is essentially a philosophy, which maintains that in order to be effective, learning should be organised and structured. The most common definition is:

    ‘A commitment to structured skills and knowledge enhancement for Personal or Professional competence’

    CPD is a common requirement of individual membership with professional bodies and Institutes. Increasingly, employers also expect their staff to undertake regular CPD activities.

    Undertaken over a period of time, CPD ensures that educational qualifications do not become obsolete, and allows for best practice and professional standards to be upheld.

    CPD can be undertaken through a variety of learning activities including instructor led training courses, seminars and conferences, e:learning modules or structured reading.

    CPD AND PROFESSIONAL INSTITUTES

    There are approximately 470 institutes in the UK across all industry sectors, with a collective membership of circa 4 million professionals, and they all expect their members to undertake CPD.

    For some institutes undertaking CPD is mandatory e.g. accountancy and law, and linked to a licence to practice, for others it’s obligatory. By ensuring that their members undertake CPD, the professional bodies seek to ensure that professional standards, legislative awareness and ethical practices are maintained.

    CPD Schemes often run over the period of a year and the institutes generally provide online tools for their members to record and reflect on their CPD activities.

    TYPICAL CPD SCHEMES AND RECORDING OF CPD (CPD points and hours)

    Professional bodies and Institutes CPD schemes are either structured as ‘Input’ or ‘Output’ based.

    ‘Input’ based schemes list a precise number of CPD hours that individuals must achieve within a given time period. These schemes can also use different ‘currencies’ such as points, merits, units or credits, where an individual must accumulate the number required. These currencies are usually based on time i.e. 1 CPD point = 1 hour of learning.

    ‘Output’ based schemes are learner centred. They require individuals to set learning goals that align to professional competencies, or personal development objectives. These schemes also list different ways to achieve the learning goals e.g. training courses, seminars or e:learning, which enables an individual to complete their CPD through their preferred mode of learning.

    The majority of Input and Output based schemes actively encourage individuals to seek appropriate CPD activities independently.

    As a formal provider of CPD certified activities, SAE Media Group can provide an indication of the learning benefit gained and the typical completion. However, it is ultimately the responsibility of the delegate to evaluate their learning, and record it correctly in line with their professional body’s or employers requirements.

    GLOBAL CPD

    Increasingly, international and emerging markets are ‘professionalising’ their workforces and looking to the UK to benchmark educational standards. The undertaking of CPD is now increasingly expected of any individual employed within today’s global marketplace.

    CPD Certificates

    We can provide a certificate for all our accredited events. To request a CPD certificate for a conference , workshop, master classes you have attended please email events@saemediagroup.com

    Event Title

    Headline

    Text
    Read More

    I would like to speak at an event

    I would like to attend an event

    I would like to sponsor/exhibit at an event

    SIGN UP OR LOGIN

    Sign up
    Forgotten Password?

    Contact SAE Media Group

    UK Office
    Opening Hours: 9.00 - 17.30 (local time)
    SAE Media Group , Ground Floor, India House, 45 Curlew Street, London, SE1 2ND, United Kingdom
    Tel: +44 (0) 20 7827 6000 Fax: +44 (0) 20 7827 6001
    Website: http://www.smgconferences.com Email: events@saemediagroup.com
    Registered in England - SMi Group Ltd trading as SAE Media Group




    Forgotten Password

    Please enter the email address you registered with. We will email you a new password.

    Thank you for visiting our event

    If you would like to receive further information about our events, please fill out the information below.

    By ticking above you are consenting to receive information by email from SAE Media Group.
    Full details of our privacy policy can be found here https://www.smgconferences.com/privacy-legals/privacy-policy/.
    Should you wish to update your contact preferences at any time you can contact us at data@smgconferences.com.
    Should you wish to be removed from any future mailing lists please click on the following link http://www.smgconferences.com/opt-out

    Fill in your details to download the brochure

    By submitting this form you agree to our privacy policy and consent to receiving communications, you may opt out at any time.